Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Viome Life Sciences logo — We're on a mission to decode human biology in order to preve...

Viome Life Sciences

We're on a mission to decode human biology in order to prevent and reverse chronic diseases, cancers, and aging.

Founded 2016 United States Bellevue, United States 30 employees Venture round Health Care

General Information

Company Name Viome Life Sciences
Founded Year 2016
Location United States Bellevue, United States
Employees 30
Industries Health Care
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Viome Life Sciences. To contact Viome Life Sciences, visit viomelifesciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Viome Life Sciences compare?

A PDF of Viome Life Sciences and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Viome Life Sciences soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Viome Life Sciences

Viome Life Sciences, founded in 2016, is dedicated to decoding human biology to prevent and reverse chronic diseases, cancers, and aging. The company's Consumer Services (VIOME) offers a direct-to-consumer healthcare test analyzing microbial and human gene expressions utilizing proprietary technology exclusively licensed from Los Alamos National Lab. This provides individuals with health insights and personalized nutrition plans. Viome's Health Sciences division uses state-of-the-art artificial intelligence to analyze data from the world's largest gene expression database to identify root causes of diseases and develop precision therapeutics. The company's focus includes prediction, early diagnostics, prognostics, and precision therapeutics, leveraging advanced AI methods to discover biomarkers, diagnose conditions, develop companion diagnostics, and target the root cause of diseases. Viome recently received a venture round investment on 20 December 2022 from SquareOne Capital. Viome operates from the United States and aims to make illness optional through its innovative approach to personalized healthcare.

Business keywords: genomics, microbiome analysis, precision medicine, AI in healthcare, chronic disease prevention, cancer diagnostics, aging research, molecular biology, precision therapeutics, predictive medicine

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round Undisclosed 1
SquareOne Capital
SquareOne Capital
20 Dec 2022

Viome Life Sciences Alternatives & Competitors

View All Alternatives
Viome Life Sciences vs
Biofidelity
Biofidelity United Kingdom

Transforming human health by developing innovative technologies that unleash the potential of genomi...

Venture round
73 employees
Biotechnology, Health Care
Compare Viome Life Sciences vs Biofidelity
Viome Life Sciences vs
Aura Genetics
Aura Genetics United States

Molecular diagnostics reference laboratory

3 employees
Health Care
Compare Viome Life Sciences vs Aura Genetics
Viome Life Sciences vs
AlphaBiomics
AlphaBiomics United Kingdom

The Precision Medicine Company

Seed
3 employees
Biotechnology, Health Care
View all alternatives

FAQ About Viome Life Sciences

We're on a mission to decode human biology in order to prevent and reverse chronic diseases, cancers, and aging.
Viome Life Sciences was founded in 2016.
Viome Life Sciences is headquartered in Bellevue, United States.
Viome Life Sciences operates in Health Care. Its work centres on genomics, microbiome analysis, precision medicine and AI in healthcare.
Viome Life Sciences has approximately 30 employees.
Viome Life Sciences has completed 1 funding round. The latest funding stage is Venture round.
Top alternatives and competitors to Viome Life Sciences include Biofidelity, Aura Genetics, AlphaBiomics, Jona, ACT Genomics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Viome Life Sciences and Biofidelity are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Viome Life Sciences, https://bouncewatch.com/company/viome-life-sciences, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout